Cargando…

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development

Lassa virus (LASV), which causes considerable morbidity and mortality annually, has a high genetic diversity across West Africa. LASV glycoprotein (GP) expresses this diversity, but most LASV vaccine candidates utilize only the Lineage IV LASV Josiah strain GP antigen as an immunogen and homologous...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ibukun, Francis Ifedayo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232328/ https://www.ncbi.nlm.nih.gov/pubmed/32244402 http://dx.doi.org/10.3390/v12040386

Ejemplares similares

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

New Lineage of Lassa Virus, Togo, 2016
por: Whitmer, Shannon L.M., et al.
Publicado: (2018)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021)

Neutralizing Antibodies against Lassa Virus Lineage I
por: Buck, Tierra K., et al.
Publicado: (2022)

In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever
por: Baral, Prabin, et al.
Publicado: (2020)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Lassa virus diversity and feasibility for universal prophylactic vaccine
por: Lukashevich, Igor S., et al.
Publicado: (2019)

Immune Responses and Lassa Virus Infection
por: Russier, Marion, et al.
Publicado: (2012)

Detection of Lassa Virus, Mali
por: Safronetz, David, et al.
Publicado: (2010)

New Hosts of The Lassa Virus
por: Olayemi, Ayodeji, et al.
Publicado: (2016)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Computer aided epitope design as a peptide vaccine component against Lassa virus
por: Faisal, Ar-Rafi Md., et al.
Publicado: (2017)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
por: Heinrich, Megan L., et al.
Publicado: (2020)

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
por: Robinson, James E., et al.
Publicado: (2016)

High crossreactivity of human T cell responses between Lassa virus lineages
por: Sullivan, Brian M., et al.
Publicado: (2020)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

Etymologia: Lassa [lah sə] virus
Publicado: (2010)

Environmental Persistence and Disinfection of Lassa Virus
por: Shaffer, Marlee, et al.
Publicado: (2023)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
por: Willard, Katherine A., et al.
Publicado: (2018)

Lassa virus glycoprotein complex review: insights into its unique fusion machinery
por: Pennington, Hallie N., et al.
Publicado: (2022)

Crystal Structure of Refolding Fusion Core of Lassa Virus GP2 and Design of Lassa Virus Fusion Inhibitors
por: Zhang, Xuejiao, et al.
Publicado: (2019)

Current research for a vaccine against Lassa hemorrhagic fever virus
por: Warner, Bryce M, et al.
Publicado: (2018)

Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines
por: Murphy, Hannah, et al.
Publicado: (2022)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Improving the Breadth of the Host’s Immune Response to Lassa Virus
por: Zapata, Juan Carlos, et al.
Publicado: (2018)

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Acute Lassa Virus Encephalitis with Lassa Virus in the Cerebrospinal Fluid but Absent in the Blood: A Case Report with a Positive Outcome
por: Okokhere, Peter O., et al.
Publicado: (2018)

In silico prediction of B- and T- cell epitope on Lassa virus proteins for peptide based subunit vaccine design
por: Verma, Sitansu Kumar, et al.
Publicado: (2015)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
por: Yadouleton, Anges, et al.
Publicado: (2020)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Virus–Host Interactions Involved in Lassa Virus Entry and Genome Replication
por: Loureiro, María Eugenia, et al.
Publicado: (2019)

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion
por: Dong, Siqi, et al.
Publicado: (2023)

Biochemical characterization of the Lassa virus L protein
por: Vogel, Dominik, et al.
Publicado: (2019)

Purification and characterization of the Lassa virus transmembrane domain
por: Keating, Patrick M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmg20mvebekhcqpu5i0h1n1613